Literature DB >> 30661191

Letter to the editor: reply to Antonio Ieni "Intratumoral HER2 heterogeneity in early gastric carcinomas: potential bias in therapeutical management".

Kazuki Kanayama1,2, Hiroshi Imai3, Eri Usugi2, Taizo Shiraishi2,4, Yoshifumi S Hirokawa2, Masatoshi Watanabe2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30661191     DOI： 10.1007/s00428-019-02523-x

Source DB:  PubMed          Journal:  Virchows Arch        ISSN： 0945-6317            Impact factor:   4.064


× No keyword cloud information.
  10 in total

1.  Adverse prognosis of clustered-cell versus single-cell micrometastases in pN0 early gastric cancer.

Authors:  Liang Cao; Xiang Hu; Yi Zhang; Gang Huang
Journal:  J Surg Oncol       Date:  2011-01-01       Impact factor: 3.454

Review 2.  Impact of lymph node micrometastasis on gastric carcinoma prognosis: a meta-analysis.

Authors:  Yong-Ji Zeng; Chun-Dong Zhang; Dong-Qiu Dai
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

3.  Association of HER2 gene amplification and tumor progression in early gastric cancer.

Authors:  Kazuki Kanayama; Hiroshi Imai; Eri Usugi; Taizo Shiraishi; Yoshifumi S Hirokawa; Masatoshi Watanabe
Journal:  Virchows Arch       Date:  2018-08-17       Impact factor: 4.064

4.  Gastric cancer treated by endoscopic submucosal dissection or endoscopic mucosal resection in Japan from 2004 through 2006: JGCA nationwide registry conducted in 2013.

Authors:  Satoshi Tanabe; Shigeki Hirabayashi; Ichiro Oda; Hiroyuki Ono; Atsushi Nashimoto; Yoh Isobe; Isao Miyashiro; Shunichi Tsujitani; Yasuyuki Seto; Takeo Fukagawa; Souya Nunobe; Hiroshi Furukawa; Yasuhiro Kodera; Michio Kaminishi; Hitoshi Katai
Journal:  Gastric Cancer       Date:  2017-02-15       Impact factor: 7.370

5.  High rate of 5-year survival among patients with early gastric cancer undergoing curative endoscopic submucosal dissection.

Authors:  Haruhisa Suzuki; Ichiro Oda; Seiichiro Abe; Masau Sekiguchi; Genki Mori; Satoru Nonaka; Shigetaka Yoshinaga; Yutaka Saito
Journal:  Gastric Cancer       Date:  2015-01-24       Impact factor: 7.370

6.  HER2/neu over-expression predicts poor outcome in early gastric cancer without lymph node metastasis.

Authors:  Yongjia Yan; Li Lu; Chunna Liu; Weidong Li; Tong Liu; Weihua Fu
Journal:  Clin Res Hepatol Gastroenterol       Date:  2014-08-28       Impact factor: 2.947

7.  Discordance rate of HER2 status in primary gastric carcinomas and synchronous lymph node metastases: a multicenter retrospective analysis.

Authors:  Antonio Ieni; Valeria Barresi; Rosario Caltabiano; Alessia Caleo; Luca Reggiani Bonetti; Salvatore Lanzafame; Pio Zeppa; Rosario Alberto Caruso; Giovanni Tuccari
Journal:  Int J Mol Sci       Date:  2014-12-03       Impact factor: 5.923

8.  Significant intratumoral heterogeneity of human epidermal growth factor receptor 2 status in gastric cancer: A comparative study of immunohistochemistry, FISH, and dual-color in situ hybridization.

Authors:  Kazuki Kanayama; Hiroshi Imai; Misao Yoneda; Yoshifumi S Hirokawa; Taizo Shiraishi
Journal:  Cancer Sci       Date:  2016-02-19       Impact factor: 6.716

Review 9.  HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach.

Authors:  A Ieni; V Barresi; L Rigoli; R A Caruso; G Tuccari
Journal:  Dis Markers       Date:  2015-10-01       Impact factor: 3.434

10.  Japanese gastric cancer treatment guidelines 2014 (ver. 4).

Authors: 
Journal:  Gastric Cancer       Date:  2016-06-24       Impact factor: 7.370
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.